Used in neuroscience and biomedical research to quantify levels of the glutamate transporter 1 (GLT1) protein in human samples. This kit enables researchers to study glutamate regulation in neurological conditions such as ALS, Alzheimer's disease, epilepsy, and schizophrenia. By measuring GLT1 expression in cell cultures, cerebrospinal fluid, or brain tissue, it supports investigation into excitotoxicity, synaptic function, and potential therapeutic interventions targeting glutamate homeostasis. Widely applied in academic labs, pharmaceutical research, and clinical studies focused on neurodegenerative and neuropsychiatric disorders.